Clinical Trial Update: Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy and safety of three different latanoprost 0.005% eyedrops in subjects with primary open-angle glaucoma; current s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Latanoprost 0.005% eye drops (latanoprost)

Snippet

Sponsor: University of Catanzaro | Conditions: Intraocular Pressure (IOP), Tear Break-Up Time | Phase 4 | Status: UNKNOWN